| 1 |
Ecsédi P, Gógl G, Hóf H, Kiss B, Harmat V, Nyitray L. Structure Determination of the Transactivation Domain of p53 in Complex with S100A4 Using Annexin A2 as a Crystallization Chaperone. Structure 2020;28:943-953.e4. [PMID: 32442400 DOI: 10.1016/j.str.2020.05.001] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Strand E, Hollås H, Sakya SA, Romanyuk S, Saraste MEV, Grindheim AK, Patil SS, Vedeler A. Annexin A2 binds the internal ribosomal entry site of c-myc mRNA and regulates its translation. RNA Biol 2021;:1-18. [PMID: 34346292 DOI: 10.1080/15476286.2021.1947648] [Reference Citation Analysis]
|
| 3 |
Sharma MC, Tuszynski GP, Blackman MR, Sharma M. Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer. Cancer Lett 2016;373:27-35. [PMID: 26797420 DOI: 10.1016/j.canlet.2016.01.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 4 |
Al-Abd AM, Alamoudi AJ, Abdel-Naim AB, Neamatallah TA, Ashour OM. Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review. J Adv Res 2017;8:591-605. [PMID: 28808589 DOI: 10.1016/j.jare.2017.06.006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 5 |
Bećarević M. TNF-alpha and annexin A2: inflammation in thrombotic primary antiphospholipid syndrome. Rheumatol Int 2016;36:1649-56. [PMID: 27704162 DOI: 10.1007/s00296-016-3569-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 6 |
Patil P, Shetty P, Kuriakose N, Gollapalli P, Shetty S, Bhandary R, Vishwanatha JK, Ghate SD. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications. Int J Mol Sci 2021;22:11028. [PMID: 34681689 DOI: 10.3390/ijms222011028] [Reference Citation Analysis]
|
| 7 |
Lin Z, Zhang Q, Luo W. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions. Eur J Pharmacol 2016;793:76-81. [PMID: 27840192 DOI: 10.1016/j.ejphar.2016.10.039] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 8 |
Grindheim AK, Saraste J, Vedeler A. Protein phosphorylation and its role in the regulation of Annexin A2 function. Biochim Biophys Acta Gen Subj 2017;1861:2515-29. [PMID: 28867585 DOI: 10.1016/j.bbagen.2017.08.024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 8.6] [Reference Citation Analysis]
|
